EVEREST GROUP, LTD. (EG): what the price assumes

In the published model solve dated 2026-Q2, anchored at $377.61, EVEREST GROUP, LTD. (EG) is priced for 8.3% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/EG

Headline

FieldValue
TickerEG
CompanyEVEREST GROUP, LTD.
Sector / IndustryFinancial Services
Current price$377.61/sh
CompositionReinsurance 76% / Insurance 24%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed8.3%
Return on equity now10.2%
ROE gap-1.9pp
Price-to-book0.94x

Solve inputs: computed at a 8.6% cost of equity with 4% terminal growth over a 10-year stage, on common book equity (FY2026).

How unusual the bet is: within-range

ReferenceValue
vs own history+0.04σ
cohort percentile (of 78 peers)12
sustained it ~10 years at this level81%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.61x3justifies
Earnings0.74x1justifies
Relative0
Growth0

Families that justify the price: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 5.8%); the inversion above states its own rate.

Per-Model Detail (n=4)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthno
Bank Fair Value (P/TBV)$700.490.54xyesTBVPS $402.42 × 1.74x (ROE (TTM) 12.4% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative ValuationRelativenoP/E 11x (static sector reference · 2026-04), scenarios: 9.3x / 11.0x / 12.6x (bear / base = reference held flat / bull), EV/EBITDA 10x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$539.370.70xyesBV/sh $402.42, ROE (TTM) 12.4%, ke 9.3%
Two-Stage Excess ReturnAsset$620.140.61xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowthnoRev $16.8B, growth -5% (input: historical growth; tapered), Terminal P/S: 0.7x / 0.9x / 1.0x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelativenoEPS $47.23, growth 35% (input: historical EPS growth), PEG=0.22 (Undervalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAssetno
Graham NumberAsset$653.950.58xyes√(22.5 × EPS $47.23 × BVPS $402.42) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsnoEPS $47.23 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelativeno
PEG Fair ValueRelativenoEPS $47.23 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$510.590.74xyesEPS $47.23 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

The issuer is a funded financial business. Debt, interest, and cash flows are operating inputs, so industrial EV, net-debt, WACC, and free-cash-flow lenses do not apply; value the common-equity claim with book, earnings, capital, and payout economics.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Reinsurancefinancialequity$11.7bwithheldunresolved standalone equity facts required
Insurancefinancialequity$3.7bwithheldunresolved standalone equity facts required

No unit-level total common-equity value is stated. Each financial unit requires supported standalone common equity, normalized earnings, capital adequacy, and payout capacity. Consolidated debt, interest, and cash are operating balances, not an enterprise-to-equity bridge; company-level book, earnings, capital, and payout lenses remain the coherent cross-checks.

Solvency

FieldValue
Share count CAGR (buyback)-0.1%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

The turn shows up first in the loss line. In the March quarter Everest earned 653 million dollars against 210 million dollars in the same quarter of 2025, and the arithmetic behind that jump is not mysterious. Catastrophe losses net of recoveries fell to 130 million dollars from 472 million. Pre-tax underwriting income came to 316 million dollars. The group combined ratio, which is simply what it costs to pay claims and run the business for every dollar of premium earned, landed at 91.2%. Anything under 100 means the underwriting itself made money before a cent of investment return.

That last distinction is what makes an insurer's earnings interesting. Everest collects premiums today and pays claims over years, and it invests the difference in the meantime. Net investment income reached 567 million dollars in the quarter, up from 491 million, helped by alternative investment returns, on top of the 2.0 billion dollars the portfolio produced across 2024. Underwriting profit and investment income are additive, and right now both are working.

Discipline explains part of the improvement, and it is expensive discipline. Gross written premium fell 18.5% year over year in the quarter, and the annual report is candid that The decrease in insurance premiums reflects portfolio actions taken in casualty lines of business, offset by growth in accident and health and other specialty lines. Shrinking the top line to fix the loss ratio is what a well-run underwriter does at this point in a cycle and what a badly run one refuses to do. The company describes its method the same way, listing careful risk selection, appropriate pricing through strict underwriting discipline and adjustments to the Company's business mix as market conditions change and saying it focuses on (re)insuring companies that effectively manage their own underwriting cycle. Reinsurers who chase premium into a softening market are the ones who write the reserve charges three years later.

The mix is also less exposed than a headline reinsurance label implies. The book runs well beyond property catastrophe: financial lines alone, covering political risk, credit, surety, mortgage and alternative risk lines of business, made up 6.9% of reinsurance gross written premiums. A reinsurer with a diversified specialty book has more places to redeploy capacity when one line stops paying.

Capital return is where the shareholder actually sees the improvement. Everest bought back 331 million dollars of its own shares during the March quarter, and across the last full year returned about 71.2% of earnings through dividends and repurchases combined. When a company trades near its stated book value, every dollar spent on repurchase retires book at roughly the price of book, which is arithmetic that works for the remaining holder in a way it does not for a company buying back stock at a large premium to what it owns.

The cohort frames why that matters. Among the larger property and casualty names, ACGL converts about 24.6% of its 19.777 billion dollars of revenue into profit and RNR about 24.2% of 11.5725 billion, while CB runs near 18.6% on 60.822 billion and TRV near 15.5% on 48.942 billion. Everest's underwriting result in the March quarter puts it back into that conversation rather than below it, and the shares are not priced as though it has arrived there.

Bear Case

Reinsurance is a cycle business, and the evidence that this cycle has peaked is not subtle. Everest's own gross written premium fell 18.5% year over year in the March quarter. Across the peer group the same pressure shows: RNR's revenue fell 7.9% over the trailing year and AIG's fell 2.3%. Prices soften when capital arrives, and the annual report names exactly where it comes from, warning that the entry of alternative capital market products and new company formations, such as Insurtech companies, provide additional sources of reinsurance and insurance capacity, which could reduce our market share and adversely affect our business. A quarter with a 91.2% combined ratio and light catastrophe losses is what the top of a cycle looks like, not the middle.

The deeper issue is that this company has recently been wrong about what it owed. The annual report discloses net unfavorable development on prior year reserves of $ 1.3 billion in 2024, of which $ 1.1 billion of unfavorable development on prior years attritional losses for the Insurance segment, and the pattern continued into the following year, where current-year attritional losses rose in part from strengthening of U.S. casualty reserves and changes in the mix of business. American casualty claims settle slowly and inflate steadily. A reserve set in 2019 for a liability claim that reaches a courtroom in 2027 is an estimate made before anyone knew what juries would award. When those estimates prove low, the correction lands on the current year's income statement, and the book value the shares are priced against was overstated the whole time.

That is why the price sits where it does. A stock trading at roughly its stated book value is a market saying, politely, that it does not fully believe the book. Every valuation approach anchored on that book or on recent earnings lands above today's price, and only the method that projects the top line forward lands below it, because the top line is shrinking. The bear reading is not that those methods are wrong. It is that they are all resting on the same balance sheet number, and one large casualty reserve adjustment moves them all together.

Catastrophe exposure has not gone anywhere either. The 130 million dollars of catastrophe losses in the March quarter followed 472 million in the same quarter a year earlier, and earlier periods carried aviation losses tied to the war in Ukraine plus a Washington D.C. aviation accident in the first quarter of 2025. Everest manages this exposure through probable maximum loss limits, but a probable maximum is a modeling output, not a contractual cap. One bad Florida season resets the earnings picture.

Business is also being handed away rather than won. The company recognized a net pre-tax expense of 81.0 million dollars connected to selling the renewal rights of its commercial retail insurance business in certain geographies to AIG, and it now reports a Legacy segment for lines it has stopped writing, which lost 22 million dollars before tax in the March quarter. Retrenchment is the correct response to a mispriced book. It is also a smaller company at the end of it.

And the price is not asking for much, which cuts both ways. It embeds a sustained return on equity of roughly 8.7% against about 10.3% recently earned. If reserves prove adequate, that is a low bar and the shares are cheap. If casualty development takes another billion-dollar bite, the return falls under the bar and the book it is measured against falls with it. The market is not pricing a growth failure here. It is pricing the possibility that the balance sheet is not finished telling the truth.

Valuation

Roughly one times book is what the market pays for this company. Work backwards from that and the price embeds a sustained return on equity of about 8.7%, against roughly 10.3% recently earned. Treat both as approximate. The unusual feature is the direction: the price requires less than the company has been delivering, which is the opposite of what most equities ask. Among firms earning at this level, about 80% held it for a decade, so the assumption is not demanding.

The methods line up accordingly, and they line up on one side. Approaches built on book value and current profitability land above the price. So does the peer earnings multiple. The only frame that lands below is the one that projects revenue forward, and it gets there by extending a slightly negative top-line trend, which is precisely what a company deliberately shrinking its casualty book produces. Read honestly, that is not four methods disagreeing about value. It is three methods valuing what the company owns and earns, and one method extrapolating a retreat the company chose.

Which makes the whole valuation a single question about the balance sheet. Everest recorded net unfavorable development on prior year reserves of $ 1.3 billion in 2024 and continued strengthening U.S. casualty reserves after that. Book value is not an observed quantity for an insurer; it is assets minus an estimate of claims not yet paid. When that estimate has been revised upward by more than a billion dollars once, the market's willingness to pay only book for it is a considered position rather than an oversight. The concrete "what has to be true" is simply that the reserves now carried are adequate. Nothing in the underwriting result answers that question, and the March quarter's 33 million dollars of favorable prior-year development came from short-tail lines, which are not where the doubt lives.

The recent operating evidence is genuinely good in the meantime. A group combined ratio of 91.2% with attritional at 88.5%, underwriting income of 316 million dollars, and net investment income of 567 million dollars produced net income of 653 million dollars in a single quarter. Against the wider property and casualty cohort, where ACGL converts about 24.6% of 19.777 billion dollars of revenue to profit and CB about 18.6% of 60.822 billion, a quarter like that is competitive rather than remarkable, but it is a long way from where the reserve charges left the company.

For a float-funded balance sheet the usual leverage and coverage lenses do not apply; what matters is capital and what management does with it. About 71.2% of the last full year's earnings went back out as dividends and buybacks, and 331 million dollars of shares were retired in the March quarter alone. The share count is fractionally higher than it was four years ago, so that recent buying is undoing dilution before it starts compounding for the holder. Buying back stock at book value is the cleanest form of capital return available to an insurer, and it is also an implicit statement by management about whether it believes its own reserves.

Catalysts

Second-quarter results and the call are scheduled for July 30, 2026 at 8:00 a.m. Eastern. The headline that will move the shares is not the combined ratio. It is the prior-year development line. In the March quarter that line was a favorable 33 million dollars, worth about nine tenths of a point off the group combined ratio, and management attributed it to short-tail business. A second consecutive quarter without adverse U.S. casualty development would be the strongest evidence available that the reserve problem is behind the company.

The March quarter itself set a high comparison. Net income of 653 million dollars, or 16.21 dollars per diluted share, came against 210 million dollars and 4.90 dollars in the first quarter of 2025, helped by a much lighter catastrophe load and net investment income of 567 million dollars. Two structural items also carried through the period: an 81.0 million dollar pre-tax expense tied to selling renewal rights for the commercial retail insurance business in certain regions to AIG, and 331 million dollars of share repurchases.

The sell side spent early July revising upward and disagreeing about how far. Bank of America lifted its target to 484 dollars from 472 with a buy rating on July 14, 2026, Mizuho to 418 dollars from 388 on July 8 while staying neutral, Cantor Fitzgerald to 390 dollars from 344 on July 8 also neutral, and Evercore ISI to 375 dollars from 365 on July 9 with an in-line rating. That spread brackets the current price rather than pointing past it, and the gap between the highest and lowest reflects the same disagreement this report describes: whether to value the company on the earnings it is now producing or on the durability of the reserves those earnings are calculated after.

Peer Cohorts (Per Segment, With Filing Citations)

Reinsurance (reported)

Insurance (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 earnings release, April 29, 2026 · Everest Group earnings call announcement, June 30, 2026 · broker research notes, July 2026

View the full interactive EG report on boothcheck